Larry Keen1, Antonio Abbate2, Gwenna Blanden3, Christen Priddie3, F Gerard Moeller4, Mobeen Rathore5. 1. Department of Psychology, Virginia State University, United States. Electronic address: LKeen@vsu.edu. 2. VCU Pauley Heart Center, Virginia Commonwealth University, United States. 3. Department of Psychology, Virginia State University, United States. 4. Institute for Drug and Alcohol Studies, Virginia Commonwealth University, United States. 5. University of Florida Center for AIDS/HIV Research, Service, and Education University of Florida, United States.
Abstract
BACKGROUND: Marijuana is a commonly used recreational substance with purported analgesic and mood enhancing properties. Many people living with HIV identify marijuana as a palliative substance. However, through its main psychoactive component, tetrahydrocannabinol (THC), is known to influence the immune system. The effects of marijuana use in people with HIV are still controversial, with very scant literature in Black adults. METHODS: The current study determined the differences in the lymphocyte count, specifically the number cluster differentiation 4 and 8 (CD4+ and CD8+), among patients who urine drug tested negative for THC (n = 70) and those who tested positive for THC (n = 25). The sample included 95 Black people living with HIV, 51% female, with a mean age of 46 ± 11 years. Participants provided a urine sample for substance use testing and a trained researcher extracted clinical data from clinical charts on the day of appointment. RESULTS: After adjusting for demographic and HIV-related covariates, THC-positive patients had significantly higher CD4+ and CD8+ counts than their THC-negative counterparts. CONCLUSION: These results extend previous HIV-related immunity findings in an underrepresented group, and suggest that THC use does not reduce immune function as measured by CD count. Further research is warranted on the overall effects of THC on immune function in HIV positive patients.
BACKGROUND:Marijuana is a commonly used recreational substance with purported analgesic and mood enhancing properties. Many people living with HIV identify marijuana as a palliative substance. However, through its main psychoactive component, tetrahydrocannabinol (THC), is known to influence the immune system. The effects of marijuana use in people with HIV are still controversial, with very scant literature in Black adults. METHODS: The current study determined the differences in the lymphocyte count, specifically the number cluster differentiation 4 and 8 (CD4+ and CD8+), among patients who urine drug tested negative for THC (n = 70) and those who tested positive for THC (n = 25). The sample included 95 Black people living with HIV, 51% female, with a mean age of 46 ± 11 years. Participants provided a urine sample for substance use testing and a trained researcher extracted clinical data from clinical charts on the day of appointment. RESULTS: After adjusting for demographic and HIV-related covariates, THC-positive patients had significantly higher CD4+ and CD8+ counts than their THC-negative counterparts. CONCLUSION: These results extend previous HIV-related immunity findings in an underrepresented group, and suggest that THC use does not reduce immune function as measured by CD count. Further research is warranted on the overall effects of THC on immune function in HIV positive patients.
Authors: Patricia E Molina; Peter Winsauer; Ping Zhang; Edith Walker; Leslie Birke; Angela Amedee; Curtis Vande Stouwe; Dana Troxclair; Robin McGoey; Kurt Varner; Lauri Byerley; Lynn LaMotte Journal: AIDS Res Hum Retroviruses Date: 2010-11-23 Impact factor: 2.205
Authors: Gilad Doitsh; Nicole L K Galloway; Xin Geng; Zhiyuan Yang; Kathryn M Monroe; Orlando Zepeda; Peter W Hunt; Hiroyu Hatano; Stefanie Sowinski; Isa Muñoz-Arias; Warner C Greene Journal: Nature Date: 2014-01-23 Impact factor: 49.962
Authors: Fabienne Marcellin; Caroline Lions; Eric Rosenthal; Perrine Roux; Philippe Sogni; Linda Wittkop; Camelia Protopopescu; Bruno Spire; Dominique Salmon-Ceron; François Dabis; Maria Patrizia Carrieri Journal: Drug Alcohol Rev Date: 2016-04-13
Authors: Anees Bahji; Yu Li; Rachel Vickers-Smith; Stephen Crystal; Robert D Kerns; Kirsha S Gordon; Alexandria Macmadu; Melissa Skanderson; Kaku So-Armah; Minhee L Sung; Fiona Bhondoekhan; Brandon D L Marshall; E Jennifer Edelman Journal: Int J Environ Res Public Health Date: 2022-05-06 Impact factor: 4.614
Authors: Gil Bar-Sela; Idan Cohen; Salvatore Campisi-Pinto; Gil M Lewitus; Lanuel Oz-Ari; Ayellet Jehassi; Avivit Peer; Ilit Turgeman; Olga Vernicova; Paula Berman; Mira Wollner; Mor Moskovitz; David Meiri Journal: Cancers (Basel) Date: 2020-08-28 Impact factor: 6.575